Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BNTX BioNTech	$112.89 -0.9%	$103.56	$76.53 ▼ $131.49	$27.14B	1.29	939,779 shs	521,908 shs
DE Deere & Company	$512.17 -1.4%	$510.73	$340.20 ▼ $533.78	$138.77B	1.08	1.34 million shs	1.05 million shs
EFSC Enterprise Financial Services	$57.17 -1.1%	$54.12	$43.33 ▼ $63.13	$2.11B	0.86	187,474 shs	155,298 shs
FL Foot Locker	$25.05 -1.1%	$22.30	$11.00 ▼ $33.94	$2.39B	1.72	4.09 million shs	2.40 million shs
MRO Marathon Oil	$28.55	$28.18	$25.54 ▼ $29.74	$15.97B	2.16	5.90 million shs	N/A
PFE Pfizer	$25.65 -0.5%	$23.89	$20.92 ▼ $31.54	$145.83B	0.58	41.68 million shs	34.84 million shs
ROST Ross Stores	$131.17 +0.2%	$138.04	$122.36 ▼ $163.60	$42.90B	1.11	2.81 million shs	2.17 million shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BNTX BioNTech	0.00%	+2.96%	+5.93%	+10.31%	+32.89%
DE Deere & Company	0.00%	-1.03%	+0.61%	+9.46%	+40.19%
EFSC Enterprise Financial Services	0.00%	-0.29%	+9.31%	+21.92%	+32.83%
FL Foot Locker	0.00%	+1.27%	+4.40%	+120.70%	+1.33%
MRO Marathon Oil	0.00%	0.00%	0.00%	0.00%	+0.35%
PFE Pfizer	0.00%	+0.81%	+4.65%	+16.06%	-11.31%
ROST Ross Stores	0.00%	-0.19%	-0.52%	-8.69%	-13.55%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BNTX BioNTech	1.6358 of 5 stars	3.4	2.0	0.0	0.0	2.2	0.8	0.0
DE Deere & Company	4.2814 of 5 stars	2.2	2.0	2.5	1.5	4.0	1.7	2.5
EFSC Enterprise Financial Services	4.4854 of 5 stars	2.5	2.0	4.2	2.5	1.5	3.3	1.9
FL Foot Locker	3.7436 of 5 stars	2.0	4.0	0.0	2.0	2.4	0.8	2.5
MRO Marathon Oil	0.6028 of 5 stars	1.2	0.0	2.5	0.0	0.0	1.7	1.3
PFE Pfizer	4.9721 of 5 stars	3.2	3.0	4.2	4.5	2.6	1.7	3.1
ROST Ross Stores	4.8516 of 5 stars	3.4	3.0	3.3	2.0	3.1	1.7	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BNTX BioNTech	2.83	Moderate Buy	$137.91	22.17% Upside
DE Deere & Company	2.48	Hold	$515.19	0.59% Upside
EFSC Enterprise Financial Services	3.00	Buy	$64.33	12.53% Upside
FL Foot Locker	2.00	Hold	$21.20	-15.37% Downside
MRO Marathon Oil	2.40	Hold	$30.50	6.83% Upside
PFE Pfizer	2.45	Hold	$28.55	11.31% Upside
ROST Ross Stores	2.82	Moderate Buy	$158.94	21.17% Upside

Current Analyst Ratings Breakdown

Latest PFE, DE, EFSC, MRO, FL, ROST, and BNTX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/10/2025	BNTX BioNTech	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$132.00 ➝ $133.00
7/2/2025	ROST Ross Stores	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$135.00 ➝ $150.00
6/25/2025	BNTX BioNTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$138.00
6/16/2025	BNTX BioNTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$145.00 ➝ $138.00
6/13/2025	ROST Ross Stores	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$141.00 ➝ $154.00
6/6/2025	DE Deere & Company	Melius Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
6/6/2025	DE Deere & Company	Melius Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
6/5/2025	BNTX BioNTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$134.00 ➝ $145.00
6/3/2025	BNTX BioNTech	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$151.00 ➝ $155.00
6/2/2025	BNTX BioNTech	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$112.00
5/30/2025	DE Deere & Company	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$550.00 ➝ $525.00

(Data available from 7/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BNTX BioNTech	$2.98B	9.11	N/A	N/A	$87.61 per share	1.29
DE Deere & Company	$44.46B	3.12	$33.92 per share	15.10	$84.11 per share	6.09
EFSC Enterprise Financial Services	$539.14M	3.92	$5.42 per share	10.55	$47.19 per share	1.21
FL Foot Locker	$7.99B	0.30	$3.50 per share	7.16	$30.66 per share	0.82
MRO Marathon Oil	$6.70B	2.38	$6.49 per share	4.40	$20.44 per share	1.40
PFE Pfizer	$62.46B	2.33	$4.36 per share	5.88	$15.62 per share	1.64
ROST Ross Stores	$21.26B	2.02	$7.69 per share	17.06	$16.70 per share	7.85

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BNTX BioNTech	-$719.92M	-$3.40	N/A	N/A	N/A	-27.37%	-3.94%	-3.41%	8/4/2025 (Estimated)
DE Deere & Company	$7.10B	$20.67	24.78	23.25	3.25	12.40%	24.39%	5.32%	8/13/2025 (Estimated)
EFSC Enterprise Financial Services	$185.27M	$5.10	11.21	10.89	N/A	20.92%	11.14%	1.28%	7/28/2025 (Estimated)
FL Foot Locker	$12M	-$3.77	N/A	14.48	2.10	-4.54%	3.65%	1.52%	8/27/2025 (Estimated)
MRO Marathon Oil	$1.55B	$2.33	12.25	12.92	N/A	19.73%	12.80%	7.35%	N/A
PFE Pfizer	$8.03B	$1.38	18.59	8.47	0.93	12.62%	20.33%	8.53%	8/5/2025 (Estimated)
ROST Ross Stores	$2.09B	$6.33	20.72	19.64	2.51	9.79%	38.77%	14.16%	8/20/2025 (Estimated)

Latest PFE, DE, EFSC, MRO, FL, ROST, and BNTX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	PFE Pfizer	$0.57	N/A	N/A	N/A	$13.43 billion	N/A
8/4/2025	Q2 2025	BNTX BioNTech	-$1.38	N/A	N/A	N/A	$161.26 million	N/A
7/28/2025	Q2 2025	EFSC Enterprise Financial Services	$1.21	N/A	N/A	N/A	$166.82 million	N/A
5/29/2025	Q1 2026	FL Foot Locker	-$0.07	-$0.07	N/A	-$3.81	$1.86 billion	$1.79 billion
5/22/2025	Q1 2026	ROST Ross Stores	$1.44	$1.47	+$0.03	$1.47	$4.94 billion	$4.98 billion
5/15/2025	Q2 2025	DE Deere & Company	$5.72	$6.64	+$0.92	$6.64	$10.80 billion	$11.17 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/28/2025	Q1 2025	EFSC Enterprise Financial Services	$1.17	$1.31	+$0.14	$1.31	$162.83 million	$18.48 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BNTX BioNTech	N/A	N/A	N/A	N/A	N/A
DE Deere & Company	$6.48	1.27%	N/A	31.35%	4 Years
EFSC Enterprise Financial Services	$1.20	2.10%	N/A	23.53%	11 Years
FL Foot Locker	N/A	N/A	N/A	N/A	N/A
MRO Marathon Oil	$0.44	1.54%	N/A	18.88%	2 Years
PFE Pfizer	$1.72	6.71%	N/A	124.64%	16 Years
ROST Ross Stores	$1.62	1.24%	N/A	25.59%	6 Years

Latest PFE, DE, EFSC, MRO, FL, ROST, and BNTX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
5/28/2025	DE Deere & Company	quarterly	$1.62	1.28%	6/30/2025	6/30/2025	8/8/2025
4/25/2025	EFSC Enterprise Financial Services	quarterly	$0.30	2.2%	6/16/2025	6/16/2025	6/30/2025
5/21/2025	ROST Ross Stores	quarterly	$0.4050	1.06%	6/10/2025	6/10/2025	6/30/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BNTX BioNTech	0.01	10.18	10.02
DE Deere & Company	1.76	2.11	1.89
EFSC Enterprise Financial Services	0.34	0.89	0.89
FL Foot Locker	0.17	1.64	0.49
MRO Marathon Oil	0.40	0.69	0.61
PFE Pfizer	0.64	1.26	0.96
ROST Ross Stores	0.18	1.55	0.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BNTX BioNTech	15.52%
DE Deere & Company	68.58%
EFSC Enterprise Financial Services	72.21%
FL Foot Locker	N/A
MRO Marathon Oil	77.24%
PFE Pfizer	68.36%
ROST Ross Stores	86.86%

Insider Ownership

Company	Insider Ownership
BNTX BioNTech	19.20%
DE Deere & Company	0.29%
EFSC Enterprise Financial Services	2.30%
FL Foot Locker	1.20%
MRO Marathon Oil	0.35%
PFE Pfizer	0.06%
ROST Ross Stores	2.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BNTX BioNTech	6,772	240.39 million	194.24 million	Optionable
DE Deere & Company	75,800	270.83 million	270.04 million	Optionable
EFSC Enterprise Financial Services	1,256	36.93 million	36.12 million	Optionable
FL Foot Locker	47,306	95.44 million	94.30 million	Optionable
MRO Marathon Oil	1,681	559.41 million	557.45 million	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable
ROST Ross Stores	107,000	327.07 million	319.88 million	Optionable

PFE, DE, EFSC, MRO, FL, ROST, and BNTX Headlines

Recent News About These Companies

Slow Capital Inc. Purchases 27,438 Shares of Ross Stores, Inc. (NASDAQ:ROST)

1 hour ago | marketbeat.com

Stephens Investment Management Group LLC Acquires 42,429 Shares of Ross Stores, Inc. (NASDAQ:ROST)

3 hours ago | marketbeat.com

Cerity Partners LLC Purchases 53,846 Shares of Ross Stores, Inc. (NASDAQ:ROST)

4 hours ago | marketbeat.com

MQS Management LLC Purchases Shares of 4,929 Ross Stores, Inc. (NASDAQ:ROST)

July 13 at 8:46 AM | marketbeat.com

Ross Stores, Inc. (NASDAQ:ROST) Shares Sold by Xponance Inc.

July 13 at 5:10 AM | marketbeat.com

Ross Stores, Inc. (NASDAQ:ROST) Stock Holdings Decreased by Brown Advisory Inc.

July 12 at 4:38 AM | marketbeat.com

Ross Stores, Inc. (NASDAQ:ROST) Shares Sold by Nisa Investment Advisors LLC

July 11 at 5:48 AM | marketbeat.com

Crossmark Global Holdings Inc. Sells 1,989 Shares of Ross Stores, Inc. (NASDAQ:ROST)

July 11 at 4:46 AM | marketbeat.com

Aurdan Capital Management LLC Sells 7,580 Shares of Ross Stores, Inc. (NASDAQ:ROST)

July 10, 2025 | marketbeat.com

Moloney Securities Asset Management LLC Sells 6,062 Shares of Ross Stores, Inc. (NASDAQ:ROST)

July 10, 2025 | marketbeat.com

Ross Stores, Inc. (NASDAQ:ROST) Shares Purchased by Flossbach Von Storch SE

July 9, 2025 | marketbeat.com

Ross Stores, Inc. (NASDAQ:ROST) Shares Sold by DekaBank Deutsche Girozentrale

July 9, 2025 | marketbeat.com

Ross Stores, Inc. (NASDAQ:ROST) Shares Acquired by China Universal Asset Management Co. Ltd.

July 9, 2025 | marketbeat.com

Envestnet Asset Management Inc. Boosts Holdings in Ross Stores, Inc. (NASDAQ:ROST)

July 9, 2025 | marketbeat.com

ROST - Ross Stores Inc Executives - Morningstar

July 8, 2025 | morningstar.comM

ROST - Ross Stores Inc Price vs Fair Value - Morningstar

July 8, 2025 | morningstar.comM

Ross Stores, Inc. (NASDAQ:ROST) Shares Sold by Allspring Global Investments Holdings LLC

July 8, 2025 | marketbeat.com

Ross Stores, Inc. (NASDAQ:ROST) Shares Sold by Bank of New York Mellon Corp

July 7, 2025 | marketbeat.com

IFM Investors Pty Ltd Has $8.56 Million Stake in Ross Stores, Inc. (NASDAQ:ROST)

July 6, 2025 | marketbeat.com

D.A. Davidson & CO. Acquires 3,779 Shares of Ross Stores, Inc. (NASDAQ:ROST)

July 5, 2025 | marketbeat.com

11,549 Shares in Ross Stores, Inc. (NASDAQ:ROST) Acquired by Aurora Private Wealth Inc.

July 4, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
3 AI Infrastructure Stocks With Strong Growth, Not Hype
By Chris Markoch | June 26, 2025
View 3 AI Infrastructure Stocks With Strong Growth, Not Hype

PFE, DE, EFSC, MRO, FL, ROST, and BNTX Company Descriptions

BioNTech NASDAQ:BNTX

$112.89 -1.03 (-0.90%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$111.18 -1.71 (-1.52%)

As of 08:02 AM Eastern

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.

Deere & Company NYSE:DE

$512.17 -7.03 (-1.35%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$516.40 +4.23 (+0.82%)

As of 08:02 AM Eastern

Deere & Co. engages in the manufacture and distribution of equipment used in agriculture, construction, forestry, and turf care. It operates through the following segments: Agriculture and Turf, Construction and Forestry, and Financial Services. The Agriculture and Turf segment focuses on the distribution and manufacture of a full line of agriculture and turf equipment and related service parts. The Construction and Forestry segment offers machines and service parts used in construction, earthmoving, road building, material handling and timber harvesting. The Financial Services segment finances sales and leases by John Deere dealers of new and used agriculture and turf equipment and construction and forestry equipment. The company was founded by John Deere in 1837 and is headquartered in Moline, IL.

Enterprise Financial Services NASDAQ:EFSC

$57.17 -0.66 (-1.14%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$57.18 +0.01 (+0.02%)

As of 07/11/2025 04:10 PM Eastern

Enterprise Financial Services Corp operates as the holding company for Enterprise Bank & Trust that offers banking and wealth management services to individuals and corporate customers primarily in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico. It provides checking, savings, money market accounts, and certificates of deposit. The company also provides commercial and industrial, commercial real estate, real estate construction and development, residential real estate, small business administration, agricultural, consumer, and other loan products. In addition, it offers treasury management and international trade services; tax credit brokerage services; life insurance premium and sponsor finance; tax credit related lending; other deposit accounts, such as community associations, property management, third party escrow, and trust services; treasury management product and services; customized solutions and products; cash management; fiduciary, investment management, and financial advisory services; and customer hedging products, including international banking, card services, and tax credit businesses. Further, the company provides online, device applications, text, and voice banking; remote deposit capture; internet banking, mobile banking, cash management, positive pay services, fraud detection and prevention, automated payables, check image, and statement and document imaging; and controlled disbursements, repurchase agreements, and sweep investment accounts. Enterprise Financial Services Corp was founded in 1988 and is headquartered in Clayton, Missouri.

Foot Locker NYSE:FL

$25.05 -0.27 (-1.07%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$25.06 +0.02 (+0.06%)

As of 08:00 AM Eastern

Foot Locker, Inc., through its subsidiaries, operates as a footwear and apparel retailer in North America, Europe, Australia, New Zealand, Asia, and the Middle East. Its brand portfolio includes Foot Locker, a brand comprising sneakers and apparel; Kids Foot Locker, which offers athletic footwear, apparel, and accessories for children; and Champs Sports that operates as a mall-based specialty athletic footwear and apparel retailer. The company also provides its products under the WSS brand, an athletic-inspired retailer; and atmos brand, a digitally led culturally connected brand featuring sneakers and apparel. It offers its products through physical stores, various e-commerce sites, and mobile apps. The company was formerly known as Venator Group, Inc. and changed its name to Foot Locker, Inc. in November 2001. The company was founded in 1879 and is headquartered in New York, New York.

Marathon Oil NYSE:MRO

Marathon Oil Corporation, an independent exploration and production company, engages in exploration, production, and marketing of crude oil and condensate, natural gas liquids, and natural gas in the United States and internationally. The company also produces and markets products manufactured from natural gas, such as liquefied natural gas and methanol. In addition, it owns and operates Sugarloaf gathering system, a natural gas pipeline. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in December 2001. Marathon Oil Corporation was founded in 1887 and is headquartered in Houston, Texas.

Pfizer NYSE:PFE

$25.65 -0.13 (-0.50%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$25.60 -0.04 (-0.18%)

As of 08:07 AM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Ross Stores NASDAQ:ROST

$131.17 +0.31 (+0.24%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$131.00 -0.17 (-0.13%)

As of 08:02 AM Eastern

Ross Stores, Inc., together with its subsidiaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dd's DISCOUNTS brand names in the United States. Its stores primarily offer apparel, accessories, footwear, and home fashions. The company's Ross Dress for Less stores sell its products at department and specialty stores to middle income households; and dd's DISCOUNTS stores sell its products at department and discount stores for households with moderate income. Ross Stores, Inc. was incorporated in 1957 and is headquartered in Dublin, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFE, DE, EFSC, MRO, FL, ROST, and BNTX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFE, DE, EFSC, MRO, FL, ROST, and BNTX Earnings

Compare Dividends

Latest PFE, DE, EFSC, MRO, FL, ROST, and BNTX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFE, DE, EFSC, MRO, FL, ROST, and BNTX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PFE, DE, EFSC, MRO, FL, ROST, and BNTX Company Descriptions

BioNTech NASDAQ:BNTX

Deere & Company NYSE:DE

Enterprise Financial Services NASDAQ:EFSC

Foot Locker NYSE:FL

Marathon Oil NYSE:MRO

Pfizer NYSE:PFE

Ross Stores NASDAQ:ROST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools